Formulation and Evaluation of Green Synthesis of Silver Nanoparticles from Neem and Coconut

Silver nanoparticles (AgNPs) are silver particles in very small sizes. Their sizes are between 1 and 100 nm [1]. The small size results in special properties of AgNPs. These are high surface area and reactivity [2]. AgNPs enhance drug delivery in drugs. They enhance the bioavailability [3]. The bioavailability refers to the extent to which the drug gets into the body. AgNPs also fight microbes. This aids in the treatment of the infections [4].

AgNPs are synthesized using natural materials in green synthesis. It avoids the use of toxic chemicals (or they can avoid it) [5]. Conventional practices employ draining agents such as sodium borohydride. These are damaging to the environment [6]. The use of plant extracts occurs in green methods. Reducing agents are found in the plants. These are eco-safe and sustainable [7]. Green synthesis minimizes toxicity in the pharmaceuticals. It renders AgNPs any safer to be used by humans [1].

Neem ( Azadirachta indica) is an Indian tree. It contains such compounds as azadirachtin in its leaves and bark. These are reducer [8, 9]. The coconut or Cocos nucifera is ubiquitous in the tropics. It contains polyphenols in its husk as well as water. These are assisting in synthesis [10, 11]. The two plants are not expensive and are in abundance. They embrace sustainable manufacturing [12].

This review also seeks to summarize neem and coconut green synthesis. It emphasizes on formulation and evaluation. The preparation of AgNPs is called formulation. Assessment examines its quality. The review entails fundamentals, procedures and uses. It underlines the relevance of pharmaceutical. This encompasses stability and efficacy of the drugs [3].

It begins with AgNPs fundamentals. Section 3 includes real estate and green requirement. Part 4 provides description of plant extracts. Part 5 and 6 describe formulation and characterization. Section 7 determines stability and safety. In section 8, applications are discussed. The 9-11 are concerned with challenges, future, and conclusion.

The literature indicates that green AgNPs enhance the wound dressings. They have fewer risks of infection [13]. Their purpose is to choose drugs in better ways in nanomedicine [14]. The present review has used 30 recent references. It is consistent with pharmaceutical journals.

Figure 1: AgNPs (10-50 nm) interact with bacterial membranes for antimicrobial action.

2. Basics of Silver Nanoparticles

This section has been linked to the introduction and is based on the preparatory thoughts in the introduction. It outlines the key principles of AgNPs, its fundamental properties, application of such nanoparticles in pharmaceutical business and the logic of such nanoparticles being used through green synthesis. This will be a clear stipulation to any additional information about formulation and assessment relative to sustainable methods to drug development.

1. 1. Properties and Uses

AgNPs have their special natures of physics. They exhibit surface plasmon resonance. This produces a change in the color of solutions [2]. The particles in question are often spherical. They have a size of between 10 and 50 nm [1]. The smaller the size the more reactive [2].

AgNPs have an advantage of enhancing drug formulation in the pharmaceutical industry. They carry drugs to targets. On the contrary, this increases the efficacy of treatment [3]. AgNPs are also antimicrobial agents. They lead to disturbance of bacterial walls [4]. The studies showed inhibition of E. coli was 95 percent.

Applications Uses Wound dressings. AgNPs speed healing. They aid in reduction of inflammation [13]. They enhance bioavailability where drug delivery is concerned [3]. To give an example, neem AgNPs stabilize antibiotics [8].

One study used neem extract. It made 20 nm AgNPs. These had high rates of stability [13]. Another used coconut shell. Particles were 30 nm. They possessed a high degree of antioxidants [15].

Limits include aggregation. This reduces efficiency [12]. Overall, the pharma applications have been facilitated by the properties.

Table 1: Properties of AgNPs from neem and coconut.

1. 2. Why Green Synthesis?

There is a demand to green synthesize in the pharmaceuticals. It allows a decrease in the degradation of the environment [5]. The traditional ways are a source of waste. Plants are used in green practices in a bid to reduce [6].

Benefits include low cost. Plants are renewable. It avoids toxins. It is less harmful to human use, as a result [7].

In pharma, green AgNPs are not very toxic. They are level to regulations [1]. According to the research, there exist green impacts [3].

One limit is variable yield. The outcomes depend on the quality of the plants [12].

Green production fosters sustainability. It can be implemented in developing countries [10]. Summary: Green processes are safe and effective AgNPs drugs.

3. P lant Extracts in Green Synthesis

The present section expounds on the fundamentals to discuss particular plant extracts utilized in green synthesis. It gives information about neem and coconuts, their action in silencing silver ions and pharmaceutical implications, which offers a basis of the formulation procedures in subsequent parts. This emphasis is given on the sources of a sustainable nature that increases the stability of drugs in therapeutic uses and minimizes the toxicities of the drugs used.

1. 1. Neem Leaf and Bark Extracts

Neem extracts are obtained either through leaves or bark. Leaves have flavonoids. These cut the silver ions [8].

One of the studies mentioned neem leaf extract. It mixed with silver nitrate. Color changed to brown. Particles were 31.5 nm [14]. Findings indicated that the shape was spherical. The rate of antimicrobial was 90 against S. aureus [14].

Another study used bark. Particles were 25 nm. Wound healing showed a high level of in vitro efficacy [16].

One of the limits is seasonal variations. Extracts can be different [9].

1. 2. Coconut Husk and Water Extracts

Coconut husk has tannins. Water has sugars. These are capping agents [10].

A study used coconut water. AgNPs were 20 nm. They demonstrated 66% of the antioxidant activity [11].

Husk extract prepared fine particles of 40nm size. The antibacterial rates were of 95% [15].

Low yield of water is one of the constraints [17].

Summary: Both extracts make it possible to synthesize green. They endorse the utilization of pharma such as antimicrobials [12].

Figure 2: Steps include drying, grinding, and boiling in water.

4. Formulation Methods for Synthesis

The section is a continuation of the plant extracts in which it outlines the formulation process of the green synthesis of AgNPs. It is made up of process and functional steps of the largest sections, such practices will guarantee the low cost and environmental-friendly manufacture that may be implemented in the pharmaceutical industry as scalable drug delivery systems. This provides practical ideas to the respective researchers who wish to seek mechanisms of how to create stable, biocompatible formulations on the basis of such formulations with greater therapeutic value.

1. 1. Step-by-Step Green Synthesis Process

The green synthesis is induced by preparation of extract. The use of coconut husks or coconut leaves is used to give it neem. Dry them under shade. Grind into powder [8].

The powder is heated using the distilled water. Filter the mixture. To extract it, this is applied [14].

After this, the silver nitrate solution is added. It is normally used at 1 mM. Agitate under room temperature or heat to maximum of 60 deg C [13]

Stir for 30-60 minutes. The change of the yellow color into brown could be considered as a signal of the AgNP preparation [16].

Centrifuge the solution. Wash pellets with water. Dry obtain AgNPs [11]

Maximisation of production of neem was made in one of the studies. They had a percentage yield of 85 percent and it had 20 nm particles [5]. Findings showed equal distribution.

Husk extract required a lot of time to mix the case containing coconuts. It led to the formation of 75 percent and 35nm particles [15].

The use of the coconut water was also reverted in another research. Synthesis took 15 minutes. The size of the particles was 18 nm [10].

The weaknesses include pH sensitivity. Optimal pH is 7-9. Differences reduce the productivity [9].

This was an overall positive process in the case of pharma. It uses simple equipment.

1. 2. Role of Extract Components (e.g., Polyphenols)

Plant work the components as reducing and capping agents employed. Polyphenols, which are donors of electrons, are provided by the electrons. This reduces Ag+ to Ag0 [5].

Quercetin as flavonoid is also assisting in neem. They reduce instability of the particles [8].

One of the studies had discovered neem had azadirachtin. It capped AgNPs. Its zeta potential was -25mV [3].

Neem also contains terpenoid, which does not allow aggregation. This assists to extend a shelf life [16].

Tannin which is available in coconut husks decrease ions. They produce shields [10].

The coconut polyphenols were established through one of the researches. AgNPs had -30 mV zeta. This involved that it was extremely resolute [15].

The reducing has sugars in coconut water. They are also more biocompatible [11].

Components that are attached to limits vary. The following are the extraction conditions to be influenced on concentration [12].

These reduce the toxicity in the drugs. They are made suitable to formulations of drugs in the form of AgNPs.

Abstract: The approaches to the formulation are simple and efficient The AgNPs of regulated characteristics are made using them to devise efficient antimicrobial curative and amplified bioavailability of drugs.

Table 2: Comparison of synthesis steps for neem and coconut.

5. Characterization Techniques

This is an extended part of the formulation methods as it explains the tools of characterization of AgNPs prepared using neem and coconut extracts. It elaborates about physical and chemical techniques of measuring the size, shape, structure, and composition of particles that are vital in the pharmaceutical quality, stability and safety of particles used in drug delivery and antimicrobial preparations. The methods help to ensure biocompatibility and effectiveness that help in green nanomedicine in terms of ensuring regulatory compliance.

1. 1. Physical Methods (UV-Vis, TEM)

Physical characterization is used to verify the formation and morphology of AgNP. The spectroscopy which determines the surface plasmon resonance is UV-Vis. It shows the maxima of its uptake at 400-450 nm [2].

One of the studies had problems with the UV-Vis that used neem AgNPs. The peak was at 420 nm. It was a good sign of depreciation [8].

The coconut AgNPs were a case which showed a peak at 430 nm. This confirmed that there were particles [10].

Size and shape are discrete images revealed by Transmission Electron Microscopy(TEM). It provides photos with a high quality [1].

A neem test revealed the manifestation of the spherical 15-30 nm particles. Distribution was also even [14].

TEM through AgNPs of coconut husk was 25-40 nm. There was not much aggregation in them [15].

In the other study, there was a mixture of UV-Vis and TEM. Neem AgNPs size was 20 nm, and 0.2 polydispersity index (PDI) [13].

Figure of limitation of UV- Vis is also overlapping with other different metals. TM requires the expensive equipment [12].

In medicine, it is the technique of a uniform particle size. This does have an impact on bioavailability.

1. 2. Chemical Methods (XRD, FTIR)

The chemical characterization measures the crystallinity and surface chemistry. X-ray Diffraction (XRD) is used to know crystal structure. Theverify 38°, 44°, 64° and 77° face-centered cubic silver [7].

In one of the studies, neem AgNPs were utilized and XRD was performed on the neem. It showed sharp peaks. Crystallites dimensions were 22 nm [16].

XRD used in the creation of coconut proved the purity. No heaps of impurities were seen [11].

Fourier Transform Infrared Spectrophotometer is used to detect the functional groups. It shows the preventing bonds of plant capping specialists [5].

At 3400 cm?¹, O-H groups were the indicated direction of FTIR of neem AgNPs. This determined the limiting of polyphenols [9].

The C=O peaks of coconut AgNPs were found at 1600 cm?¹. It had the interactions of tannins [15].

Combined XRD and FTIR were studied. Stable coating of the neem particles was discovered in it [3].

Restrictions Both XRD accepts dry samples. Groups may not be able to be quantified by the FTIR [6].

These are indicative of non-toxicating finishes in pharma. They enhance drug stability.

Summary: The approaches to characterization convey comprehensive data about AgNPs. They can be used in medicine where they guarantee quality with regard to enhanced therapeutic effects and reduced toxicity in antimicrobial therapy.

[Figure 3: Characteristic peak at 420-450 nm confirms nanoparticle formation and stability.]

6. Evaluation of Nanoparticles

In this part development, characterization processes have an emphasis on the analysis of AgNPs of neem and coconut extracts. It has stability, size control, toxicity and safety trials that are very important in pharmaceutical validation. The tests ensure the AgNPs meet the criteria of drug delivery, biovailability, and therapeutic safety and, thus, can be utilized in antimicrobial agents, in addition to wound healing products.

1. 1. Stability and Size Control

In the measurement of time-resistance of AgNPs in aggregation, the stability assessment is employed. alpha represents the level of the surface charge. The good stability is signified by any value below -30 mV [2].

One study tested neem AgNPs. Zeta potential was -35 mV. The shelf life of the particles was 3 months [14].

Stability of coconut AgNPs in the case was considered using sedimentation. Settling was not done after 60 days [15].

Sizing control is done by the use of the dynamic light scattering (DLS). It measures hydrodynamic diameter [1].

An experiment on the size was performed at a limit setting of 25 nm by controlling the concentration of the extract. Polydispersity was also not high with a value of 0.15 [13].

Optimization of pH The pH of the coconut water was leveled [11].

The other research was a mixture of DLS and storage examinations. Significantly, the Neem AgNPs did not undergo an enlargement in size [3].

There is a limit on environmental aspects like temperature. It brings about aggregation caused by high heat [12].

The controlled drug release is improved by the size of the stables in drugs.

1. 2. Toxicity and Safety Tests

The toxicity test establishes the level of safety of AgNP on human beings. The samples that can be used in an in-vitro test are HEK-293 [4].

In case of fibroblast cells, one study tested the neem AgNPs. The IC50 was above 100 ug/mL, and it indicated a low level of toxicity [16].

The result of MTT assays showed no cytotoxicity by the Coconut agNPs at a concentration of 50 ug/ml [10].

Animal testing entails animal modeling and in vivo animal testing. By mouth, it confirms the effects on the organs [7].

The rat study on neem AgNP did not confirm the liver damage in the case of 10 mg/kg dose of the product [9].

Tests in safety of pharma are in form of hemolysis. Blood compatibility can be equated with low hemolysis [5].

Hemolysis by the Coconut AgNPs was 5%, which is safe to be applied topically [15].

Dose effects are associated with limits. The doses of high concentrations are dangerous [6].

Green synthesis is not toxic as compared to chemical processes.

Summary: In the stability and safety tests of the green AgNPs of neem and coconut, it is found that the two are stable and safe. They are used to promote pharmaceutical use where they have minimal toxicity and controlled characteristics to provide superior responses in drugs deliveries and therapeutics.

Figure 4: Green synthesis uses natural agents to make nanoparticles